Eye test may predict who benefits from blood pressure drug for schizophrenia
NCT ID NCT04986072
First seen Dec 15, 2025 · Last updated May 05, 2026 · Updated 20 times
Summary
This study tested whether a drug called sodium nitroprusside (normally used for blood pressure) could reduce schizophrenia symptoms in people with early-stage illness. Researchers used a special eye scan to see if changes in tiny blood vessels in the retina could predict who would respond best. The study was stopped early after enrolling only 1 person, so no conclusions can be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.